Infant lymphoblastic leukemia: a single centers 10 year experience

Creative Commons License

Yaman-Bajin I., Aytac Ş. S., Kuskonmaz B. B., Uckan-Cetinkaya D., ÜNAL Ş., GÜMRÜK F., ...More

TURKISH JOURNAL OF PEDIATRICS, vol.61, no.3, pp.325-329, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 61 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.24953/turkjped.2019.03.002
  • Journal Name: TURKISH JOURNAL OF PEDIATRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.325-329
  • Hacettepe University Affiliated: Yes

Abstract

Infant acute lymphoblastic leukemia (ALL) is a rare disease and consists of 4-5% of all childhood ALL. Despite improved survival rates in childhood ALL, infants with ALL have a worse prognosis. We aimed to evaluate the clinical features and treatment outcomes of our patients diagnosed with infant ALL at Hacettepe University, Pediatric Hematology Department between 1 January 2008 and 1 January 2018 retrospectively.